NTLA insider trading
Intellia Therapeutics, Inc.
In the past 36 days, 1 insider sold $23K.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Michael P Dube VP, Chief Accounting Officer |
$23K 1,864 sh @ $12.43 |
−2.8% | Not pre-scheduled | Oct 2, 2026 Filed Oct 6, 2026 |